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Abstract 
 
Cyanobacteria are common inhabitants of freshwater lakes and reservoirs throughout the 
world. Under favourable conditions, certain cyanobacteria can dominate the 
phytoplankton within a waterbody and form nuisance blooms. Case reports and anecdotal 
references dating from 1949 describe a range of illnesses associated with recreational 
exposure to cyanobacteria: hay fever-like symptoms, pruritic skin rashes and gastro-
intestinal symptoms (the latter probably related to ingestion of water) are most frequently 
reported. Some papers give convincing descriptions of allergic responses to 
cyanobacteria; others describe more serious acute illnesses, with symptoms such as 
severe headache, pneumonia, fever, myalgia, vertigo and blistering in the mouth. A 
coroner in the United States recently found that a teenage boy died as a result of 
accidentally ingesting a neurotoxic cyanotoxin from a golf course pond; this is the first 
recorded human fatality attributed to recreational exposure to cyanobacteria. One of the 
main public health concerns with exposure to freshwater cyanobacteria relates to the 
understanding that some blooms produce toxins that specifically affect the liver or the 
central nervous system. The route of exposure for these toxins is oral, from accidental or 
deliberate ingestion of recreational water, and possibly by inhalation. Cyanobacterial 
lipopolysaccharides (LPS) are also reported to be putative cutaneous, gastrointestinal, 
respiratory and pyrogenic toxins. 
 
This review introduces the topic of cyanobacteria in recreational waters with a brief 
discussion of the main cyanotoxins. A comprehensive review of anecdotal and case 
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reports of human illness attributed to recreational and occupational exposure to 
cyanobacteria follows, with discussion of some important papers. Epidemiological 
studies of recreational exposure to cyanobacteria are reviewed. Discussion of some 
water-related risk factors that may be important differential diagnoses for cyanobacteria-
related illness concludes the review. 
 
 
Introduction 
 
Cyanobacteria are a diverse group of prokaryotes that occupy a broad range of ecological 
niches by virtue of their age, having first appeared some 2.5 billion years ago, and 
specialisation. All cyanobacteria are photoautotrophic organisms, yet many can grow 
heterotrophically, using light for energy and organic compounds as a carbon source [1]. 
The cyanobacteria are a remarkably widespread and successful group, colonising 
freshwater, marine and terrestrial ecosystems, including extreme habitats such as 
Antarctic lakes, salt works and hot springs [2]. Cyanobacteria are common inhabitants of 
freshwater lakes and reservoirs throughout the world. Under favourable conditions, 
certain cyanobacteria can dominate the phytoplankton within a waterbody and form 
nuisance blooms. 
 
Cyanobacteria have come to the attention of public health workers because many 
freshwater and brackish species can produce a range of potent toxins. This observation 
was first reported over 120 years ago, when sheep, horses, dogs and pigs were seen to die 
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within hours of drinking from a lake affected by a bloom of the brackish-water 
cyanobacterium Nodularia spumigena [3]. Since then, many reports of livestock and wild 
animal deaths have appeared in the literature. Such reports have been collated and 
discussed by several authors [4-10]. Some reports are dramatic in terms of the number of 
animals affected or the rapid progression of illness and death, with mass deaths of 
thousands of animals [11], and large animals succumbing within minutes [12, 13]. 
Laboratory-based toxicological investigations have confirmed that freshwater and 
brackish cyanobacteria produce several categories of toxin that are (with one exception – 
the saxitoxins) unique to cyanobacteria. The topic of cyanobacterial toxins has been 
widely studied, and many excellent texts and reviews are available, e.g. [8, 10, 13-26]. 
Details of the principal cyanotoxin groups that are significant from the public health 
perspective of acute exposure and outcome are summarised in Table 1. 
Lipopolysaccharides, which are defining structural components of Gram-negative cell 
walls, are discussed in the accompanying review by Stewart et al [27]. Cyanobacteria are 
rich sources of bioactive compounds; structurally diverse metabolites with cytotoxic, 
tumour-promoting and enzyme-inhibiting properties are known and presumably many 
more await discovery. Some of these metabolites are discussed by Bickel et al [28] and 
Forchert et al [29].  
 
A recent report has shown that β-N-methylamino-L-alanine (BMAA), a neurotoxic non-
protein amino acid associated with an atypical motor neurone 
disease/Parkinsonism/Alzheimer’s-like dementia complex, is produced by a wide variety 
of cyanobacteria [30]. BMAA is thought to be capable of binding to endogenous proteins, 
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in which form it may function as a “slow toxin”, and may be implicated in the aetiology 
of other long-latency neurodegenerative diseases such as Alzheimer’s disease [31]. The 
public health implications of this cyanobacteria-related neurotoxicity hypothesis have 
been further discussed [32].   
 
Cyanobacteria poisoning of humans has occurred through known and suspected exposure 
to cyanotoxin-contaminated drinking water supplies [33] and reviewed in: [8, 9, 34]; 
confirmed and suspected exposure to contaminated dialysate by patients undergoing 
haemodialysis [35-39]; and through recreational and occupational contact. This review 
will concentrate on the latter exposures.  
 
 
Rationale and search criteria 
 
All references that could be found in the medical and scientific literature, including 
conference proceedings, which describe specific incidents involving human illness and 
exposure to freshwater cyanobacteria in recreational or in-field occupational settings are 
summarised in Table 2. The following citation sources were not examined for this 
exercise: 
 
• Reports of cyanobacteria-associated illness from recreational exposures to marine or 
estuarine waters 
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• Publications written in languages other than English – with the exception of the 
Russian paper by Pashkevich [40], which we were opportunistically able to have 
translated  
• Newspaper reports – with three exceptions: two reports that describe the first human 
fatality to be attributed to recreational contact with cyanobacteria [41, 42]. At the time 
this review was submitted, these were apparently the only published references to 
describe the events surrounding this tragedy, so were included here because of their 
importance. The cyanobacteria research community awaits publication of a 
comprehensive case report in the scientific or medical literature. Another news article 
supplements a cursory description of cyanobacteria-associated illnesses; both the 
news report and the scientific publication appear to describe the same incident, with 
more detail provided by the journalist [43, 44]. There are undoubtedly many more 
publications in the news media that report suspected cyanobacteria-related human and 
animal morbidity and mortality: for example Duggan [45] and Ruff [46] reported on 
cyanobacteria blooms in Nebraska lakes that were associated with two dog deaths and 
more than 40 complaints of acute eye, upper respiratory, gastrointestinal and skin 
symptoms.  
 
Anecdotal and case reports presented in this review were identified by the following 
search strategy: 
1. PubMed and Web of Science electronic databases were searched with the MeSH and 
textword string “(cyanobacter* AND disease outbreaks) OR (cyanobacter* AND 
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environmental exposure) OR (cyanobacter* AND recreation*) OR (cyanobacter* 
AND epidemiology)”.  
2. Titles and abstracts (when available electronically) were perused to determine 
suitability for inclusion. 
3. Bibliographies of identified primary papers and related review articles were reviewed 
to search for references not identified by electronic sources. 
4. Publications and other sources identified and forwarded by experts working in this 
field were included. 
 
The most recent update of the aforementioned electronic searches, conducted in June 
2005, gave 258 citations, of which 244 were English-language publications, and 14 were 
non-English-language papers. Of these 14 reports, four (3x reviews; 1x primary article) 
were identified from abstracts and/or article titles as worth perusing for the presence of 
information about health-related events associated with recreational exposure to 
cyanobacteria [47-50]. We were again able to opportunistically have two of these papers 
translated (the primary article, in Dutch, and a German review paper), but there were no 
previously unreported references in those papers to specific illness events that were 
attributed to contact with cyanobacteria [47, 48]. Therefore it does not appear that there is 
a significantly large body of unexplored literature written in languages other than English 
that could contribute to this review. We also corresponded with an author of a publication 
in Finnish that we were unable to have translated; this paper discussed cyanobacteria-
related illness in saunas [51]. The findings of that work were presented at an international 
conference, from which an English-language abstract was published. The authors 
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reported that 18 subjects (38% of those questioned) were likely to have experienced 
cyanobacteria-related symptoms [52]. 
 
 
Recreational and in-field occupational exposure to cyanobacteria: anecdotal and 
case reports 
 
Case reports and anecdotal references presented in Table 2 date from 1949 [53], and 
describe a range of illnesses associated with recreational exposure to cyanobacteria: hay 
fever-like symptoms, pruritic skin rashes and gastro-intestinal symptoms are most 
frequently reported. Some papers give convincing descriptions of allergic responses to 
cyanobacteria [53, 54]. Others describe more serious acute illnesses, with symptoms such 
as severe headache, pneumonia, fever, myalgia, vertigo and blistering in the mouth [6, 
55-57]. The first and so far only description of a fatality attributed to recreational 
exposure to cyanotoxins appeared in news reports recently. A U.S. coroner concluded 
that a teenage boy died as a result of ingesting anatoxin-a-producing cyanobacteria from 
a golf course pond, although there was an unusual sequence of events preceding the death 
insofar as the time period between exposure and death (some 48 hours) does not square 
with the known mechanisms of toxicity of purified anatoxin-a, which initiates 
pathological signs in laboratory animals within minutes of dosing [41, 42]. Recent reports 
in the scientific literature also cast uncertainty on this finding, with suggestions that the 
preliminary mass spectrometric identification of anatoxin-a in these forensic samples may 
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not be reliable [58-60]. The cyanobacteria research community awaits a comprehensive 
case report on this matter.  
 
The principal public health concerns regarding recreational exposures relate to the 
potential, presumably a now-realised potential if the aforementioned fatality is indeed 
attributable to cyanotoxin poisoning, for exposure to hazardous levels of cyanotoxins in 
untreated waters. Routes of exposure are through direct contact with skin and mucous 
membranes, via inhalation, and by ingestion, either accidental or deliberate.  
 
 
Discussion of anecdotal and case reports 
 
Some reports listed in Table 2 present scant information relevant to this topic, with little 
or no detail beyond location and the kind of illness reported [61, 62]. On the other end of 
the scale are examples of thorough, considered case reports, describing relevant medical 
history and diagnostic investigations [53, 54]. One reason for the dearth of detail may be 
that non-specific, mild and self-limiting illnesses do not merit much discussion, however, 
some references to more serious illnesses leave a great deal unanswered, for example the 
12 year-old boy who reportedly lapsed into unconsciousness for a six-hour period, and 
developed pneumonia, myalgia and arthralgia [63]. It would have been very interesting to 
know whether or not this boy had any predisposing medical conditions (e.g. diabetes, 
epilepsy) that might have explained the loss of consciousness, whether any medical 
attention was sought, and, if so, the details of his disease progression.  
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 The observation that repeated water contact in a particular lake preceded a skin eruption 
on a six year-old girl, while other bathers appeared unaffected, helped support a diagnosis 
of hypersensitivity in that case [54]. One of the few reports of mass effects, with 20-30 
children suffering conjunctival and upper respiratory symptoms during a school aquatic 
event, is tempered by the observation that that number represented about 25% of those 
exposed [64]. So hypersensitivity reactions affecting a sub-set of allergy-prone children 
may also be an explanation for the latter outbreak, although this speculation – in the 
absence of any other reported investigations – is solely based on that estimate of 25% of 
those exposed experiencing symptoms. 
 
Those reports that have indicated symptom onset time suggest that responses can be 
rapid, with some urticaria and hayfever-like symptoms commencing while subjects are 
still in the water [53, 64]. While a disparate range of signs and symptoms are listed, many 
reports describe a collective group of symptoms resembling immediate or Type-I 
hypersensitivity reactions. Immediate hypersensitivity reactions are commonly associated 
with atopy, which is the familial tendency to react to naturally occurring antigens, mostly 
proteins, through an IgE-mediated process. Atopy frequently manifests as a spectrum of 
diseases, e.g. seasonal rhinitis, conjunctivitis, asthma and urticaria. Different atopic 
illnesses often affect the same individual. A fundamental feature of Type-I 
hypersensitivity reactions is the rapid onset of symptoms – normally seconds to minutes – 
following exposure to antigens [65-69].  
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Some serious though apparently self-limiting gastro-intestinal illnesses have been 
reported after contact with cyanobacteria in recreational waters, presumably through 
ingestion of affected water. Dillenberg & Dehnel [55] describe how an adult male 
inadvertently swallowed lake water affected by a bloom of Microcystis sp. and Anabaena 
circinalis. After some three hours he developed cramping abdominal pain and nausea, 
which progressed to painful diarrhoea followed by a fever of 38.90C, severe headache, 
lassitude, myalgia and arthralgia. Such illnesses are worrying, considering the two boys 
that were sickened – one of whom subsequently died – after possible exposure to 
cyanobacteria in a golf course pond suffered acute and severe gastro-intestinal illnesses 
[41].  
 
Occupational exposures were included in this review, although some caution should be 
exercised when comparing occupational and recreational exposures. Waters that are 
obviously discoloured or visibly affected by cyanobacteria scums may be of interest to 
aquatic field workers who are keen and/or obliged to collect samples. The two incidents 
involving British soldiers and sea cadets conducting canoe capsizing activities, 
presumably under orders from their supervising officers, occurred in waters that were 
reportedly subject to a “heavy bloom of Microcystis spp” [70] and a “scum of 
Oscillatoria…” [23]. Waters that are obviously suffering a loss of visual amenity may be 
shunned by many recreational users, although avoidance behaviour in such circumstances 
cannot be taken for granted [71].  
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The other reports that are of particular interest are those grouped under “cold & flu-like 
symptoms”. Several publications describe individuals presenting with a flu-like illness, 
with signs and symptoms including fever, headache, lassitude, arthralgia, myalgia, sore 
throat, cough, diarrhoea and vomiting. A proposed explanation for this constellation of 
symptoms is that of a coordinated, cytokine-mediated, innate immune response. Fever 
and malaise are events that are directed by endogenous mediators; for further discussion 
see [71]. This spectrum of signs and symptoms also mimics those reported in volunteer 
studies of intravenous Gram-negative bacterial LPS injection [72-75]. Mammalian 
responses to LPS are mediated by inflammatory cytokines (see accompanying review by 
Stewart et al [27]). The early signs and symptoms of influenza infection (fever, myalgia, 
fatigue, drowsiness, rhinorrhoea, sore throat, headache) are mediated by pro-
inflammatory cytokines, particularly IFN-α and IL-6 [76-79]. Flu-like reactions to 
immunostimulant drugs are sometimes referred to as “acute cytokine syndromes” [80], 
and the flu-like syndrome of fever, rigors, tachycardia, malaise, headache, arthralgia and 
myalgia that accompanies interferon pharmacotherapy is thought to be due to the release 
of eicosanoids, IL-1 and TNF-α [81]. 
 
 
Epidemiology of recreational exposure to cyanobacteria 
 
Six epidemiological studies of recreational exposure to cyanobacteria were identified 
with the search strategy discussed previously: three analytical cross-sectional studies 
from the U.K. using similar survey instruments [82-84], a small case-control study from 
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Australia [85], and two larger prospective cohort studies, also from Australia [86, 87]. 
Table 3 lists the pertinent findings of these studies, which are discussed in detail below.  
 
The three cross-sectional studies were conducted by Philipp and co-workers [82-84]. 
Questionnaires were distributed to recreational users of six inland waterbodies, five of 
which experienced cyanobacteria blooms during 1990. The questionnaires elicited 
information on exposure to study waters and the presence of specific symptoms in a 
defined period prior to receiving the form. This period ranged from 14 days [83] to four 
weeks [84]. One questionnaire asked about exposure to the study water on a weekend 
when a bloom occurred some 2½ weeks previously [82]. Recreational interest groups 
were used to target likely users of the waterbodies; questionnaires were mailed to 
members of sailing and angling clubs. Site authorities distributed questionnaires at one 
study lake [84]. The results of these three studies were similar: mostly minor morbidity 
was reported, with similar disease patterns across sites.  
 
The theoretical advantages of this study type are that it is reasonably cost-effective, and 
in this context – recreational exposure to cyanobacteria – it can be conducted 
opportunistically to take advantage of any sudden-onset cyanobacteria blooms. 
Disadvantages relate to the difficulty in establishing that exposure occurred before the 
outcome [88, 89]. The studies conducted by Philipp and his team [82-84] were examples 
of analytical cross-sectional studies, in that unexposed individuals served as controls for 
statistical comparison of illness reporting.  
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A case-control study of illness rates was conducted after an extensive Anabaena 
circinalis-dominant bloom along South Australia’s Murray River in the summer of 1991-
1992 [85]. Patients presenting with gastro-intestinal (G-I) or dermatological complaints 
comprised the case group; the patient presenting after each case was identified served as 
the control group. Exposure was determined by identifying each subject’s principal 
source of water for drinking, domestic use (bathing, dishwashing) and recreation during 
the week prior to consultation. Recreational exposure was categorised as no contact, 
direct exposure to river water, or other exposure, e.g. farm dams or treated water in 
swimming pools. The study found a significantly increased risk of G-I symptoms for 
those drinking chlorinated river water, and an increased risk of G-I and cutaneous 
symptoms in those using untreated river water for domestic purposes. The study found a 
statistically non-significant increase in the relative odds of developing G-I or skin 
symptoms amongst those with recreational exposure to river water, but that risk was 
lower than for those exposed to other sources of recreational water (tank, farm dam or 
another location). The number of subjects was small for the recreational exposure 
component of the study, with only some 50 subjects (16% of the study group) reporting 
any recreational exposure during the study period [85].  
 
The advantages of a case-control design for investigating recreational exposure to 
cyanobacteria are that studies can be conducted opportunistically in response to the 
development of cyanobacteria blooms, and they are very useful for investigating 
infrequent outcomes. The study of El Saadi et al [85] has another advantage over other 
epidemiological studies into recreational exposure to cyanobacteria in that medical 
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practitioners ascertained outcome data, as opposed to self-reporting of symptoms. 
General disadvantages of the case-control design principally relate to the problem of 
recall bias, where individuals with the disease of interest tend to overestimate relevant 
past exposures [88, 89]. Because the outcome has already occurred when exposure is 
measured, people with disease may systematically overestimate (or underestimate) their 
exposure compared to disease-free controls, leading to falsely elevated (or reduced) 
measures of risk associated with exposure. Another major issue with case-control studies 
is the difficulty of identifying an appropriate control group – i.e. people who would have 
been identified as cases if they had the disease of interest.  
 
Recall bias may not be so much of a problem for investigating acute illnesses following 
recreational exposure to cyanobacteria, where a fairly short time lag between exposure 
and symptom onset can be anticipated, especially if recreational exposure is determined 
by a yes/no response. The main problem with a case-control study in this context will be 
in actually identifying cases. A case-control design would not be suitable for 
investigating outcomes from exposure to a cyanobacteria bloom in a lake adjacent to a 
city, as most recreational users who do develop symptoms would presumably seek 
medical attention after they return home, i.e. from one of a large number of medical 
practitioners. El Saadi et al [85] alluded to the difficulty of gaining the cooperation of 
medical practitioners, as they approached practices in 11 towns along the Murray River, 
yet those in three towns presumably refused to participate in their study. The diffuse 
spread of cases from point sources of exposure (a cyanobacteria-affected waterbody) 
across a large town or city would make a case-control study practically unworkable. A 
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case-control study would also be unsuitable for recruiting subjects who did not seek 
medical attention for symptoms occurring after exposure. However, a well-designed case-
control study would be valuable if geographical location is a primary consideration. This 
would require enlisting the cooperation of medical practitioners in small townships near 
to cyanobacteria-affected recreational waters that are sufficiently remote from larger 
urban centres to allow recruitment of local residents and tourists who will camp nearby. 
 
The studies by Pilotto et al [86] and Stewart et al [87] were prospective cohort studies. 
Pilotto et al [86] recruited individuals at five recreational waterbodies in three Australian 
states. Cyanobacteria blooms were anticipated at these sites, based on occurrences in 
previous years. Individuals were approached and invited to participate in the study. 
Participants completed a face-to-face interview to determine health status and recreational 
water activities; two telephone follow-up interviews were conducted at two and seven 
days following the day of recruitment into the study. Individuals who did not have water 
contact on the recruitment day served as the control group. No significant differences in 
symptom occurrence were reported at the 2nd day follow-up, but the authors concluded 
there was a significant increase in symptoms at 7 days, after excluding subjects with 
symptoms or previous recent recreational water exposure. The cohort size from which 
these significant results were drawn was rather small, with 93 exposed subjects, and 43 
unexposed controls. Pilotto et al [86] interpreted the increased symptom reporting at 7 
days but not 2 days following exposure as possibly due to delayed allergic responses, 
although so-called “late phase” allergic and asthmatic responses tend to occur some 4-24 
hours after allergen exposure [65, 90, 91].  
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 Stewart et al [87] also conducted a cohort study of recreational exposure to 
cyanobacteria. 1,331 subjects were recruited from 19 recreational waterbodies in eastern 
Australia and central and northeast Florida; subjects completed a self-administered 
questionnaire to determine recreational activity, recent illness and history of any relevant 
chronic diseases such as asthma, hay fever and eczema. A single follow-up telephone 
interview was conducted after three days post-exposure. Reference subjects were 
recruited at recreational waters unaffected by cyanobacteria; exposure categories (low, 
intermediate, high) were allocated to study subjects on the basis of cyanobacteria levels 
measured in study water samples collected on the day they were recruited into the study. 
Statistically significant increased reporting of respiratory symptoms and a pooled “any 
symptom” category occurred amongst subjects exposed to high levels of cyanobacteria, 
although symptoms were predominantly rated as mild by study subjects. A similar but 
non-significant relationship was also seen for reporting of skin, ear and fever symptom 
groups. 
 
The studies of Pilotto et al [86] and Stewart et al [87] are both examples of a prospective 
cohort design, where study subjects have their exposure status determined, and are then 
followed forward in time to observe the development of disease. For these investigations 
into recreational exposure to cyanobacteria, exposure status was determined by collecting 
water samples on the day subjects were recruited into the study; cyanobacteria were 
identified and enumerated and the resultant cell counts or biomass estimates formed the 
basis of exposure at any given site on a particular day. One of the problems with this 
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approach is that cyanobacterial blooms are dynamic and can change rapidly. Unless the 
presence of significant cyanobacterial biomass can be predicted with some degree of 
certainty, a prospective cohort design can result in wasted effort if the water samples 
reveal lower than anticipated levels of cyanobacteria. This problem undoubtedly occurred 
in some instances during the study conducted by Stewart et al [87]. One possible 
approach to dealing with this would be to conduct a historical cohort study, where a 
cohort of subjects is identified after some have experienced the outcome of interest and 
relevant exposure information is obtained from historical records (i.e. as in a prospective 
cohort study the exposure information was recorded before any outcomes occurred).  
 
Whether a cohort study is conducted prospectively or retrospectively, the basic study 
design is identical – exposed and unexposed groups are compared with respect to disease 
outcome [89]. General advantages of a cohort design are the ability to determine disease 
onset (the exposure precedes the disease), and the study of exposures in natural settings 
[88]. General disadvantages relate to confounding, which refers to differences in the 
distribution of risk factors other than the exposure of interest between exposed and 
unexposed groups. Cohort studies can be expensive and resource intensive [88]. 
 
Further discussion of some common epidemiological study designs that may be useful for 
investigating the topic of recreational exposure to aquatic cyanobacteria, with particular 
emphasis on the relative advantages and disadvantages of experimental epidemiology 
(randomised trials) is presented by Stewart [71]. 
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 Cyanobacteria and water-related disease: some complicating factors 
 
Other explanations for disease need to be considered by both clinicians and 
epidemiologists in their respective endeavours. Epidemiological studies usually aim to 
identify and adjust for confounding variables such as smoking and age of study 
participants. The following sections will discuss some freshwater-related risk factors, 
mostly microbial, that may confound epidemiological studies and complicate clinical 
diagnoses of cyanobacteria-related illness linked to recreational exposures. The final 
section of this review will discuss the possibility of misdiagnosis from the opposite 
direction: a water-borne disease outbreak in Finland that was subject to epidemiological 
scrutiny, but cyanobacterial exotoxin contamination of reticulated supplies was 
apparently not considered at the time.  
 
 
Freshwater-related dermatoses 
 
• Avian cercariae: avian cercariae are schistosome larvae for which humans are an 
accidental host. Pruritus and macules are the initial signs and symptoms; 
sometimes a diffuse erythema and urticaria can develop and last for several hours 
[92-95]. Fever, nausea and vomiting can also accompany severely affected cases 
[93, 96]. The clinical presentation of cercarial dermatitis can be difficult to 
delineate from the picture of cyanobacterial dermatitis. 
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 • Gram-negative bacteria: Aeromonas hydrophila and Chromobacterium 
violaceum are abundant in freshwater habitats. Both usually cause infection 
through a pre-existing skin wound, though the clinical picture in each case is not 
reminiscent of any of the reports listed in Table 2. A. hydrophila causes cellulitis 
and a purulent discharge; aspiration of water can cause pneumonia and 
septicaemia. C. violaceum infections present with various cutaneous signs that are 
secondary to systemic disease, including sepsis [97]. Vibrio vulnificus has 
reportedly caused soft tissue infection after contact in brackish inland waters, 
though most cases are associated with estuarine contact [98]. Pseudomonas 
aeruginosa is widely-distributed in natural and artificial aquatic environments. 
Cutaneous infection presents as an erythematous or urticarial rash some 18-24 
hours after water contact and progresses to a follicular dermatitis. Fever and 
pruritus are uncommon. Most reports of pseudomonal dermatitis are related to spa 
pool or hot-tub exposures [98, 99]. P. aeruginosa in recreational waters is a 
common cause of otitis externa, presenting as a purulent discharge [98]. 
Diagnostic criteria include culturing the organism from skin or ear swabs; the 
incubation period would also help to distinguish P. aeruginosa infection from 
cyanobacteria-related dermatoses. 
 
• Non-allergic urticaria: physical stimuli such as heat, cold and exercise can 
induce itching and hives in susceptible individuals [95, 100]. 
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 Gastro-intestinal illness 
 
• Shigellosis: Shigella outbreaks are the most commonly reported cause of disease 
associated with untreated inland recreational water in the USA, with 16 events 
affecting almost 1,300 people between 1985 and 1994 [98]. The incubation period 
is typically 2-3 days, with an upper limit of about 7 days. Illness severity is strain-
dependent, with most S. sonnei infections being mild and self-limiting, and S. 
dysenteriae type 1 associated with severe diarrhoea which may progress to a life-
threatening illness [98]. 
 
• Escherichia coli: E. coli are markers of faecal pollution in recreational waters. 
Disease outbreaks traced to enterohaemorrhagic E. coli 0157 have been reported 
from recreational water exposures [98, 101]. 
 
• Norwalk-like viruses: Various transmission routes, including recreational water 
outbreaks have been documented [101]. 
 
 
Other microbial pathogens 
 
• Naegleria fowleri: N. fowleri is a free-living thermotolerant amoeba found in 
warm or thermally polluted waters. It is the causative organism of primary 
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amoebic meningoencephalitis, a fulminating, typically fatal illness. The entry 
route is via the nasal mucosa; fit, immunocompetent children and young adults 
with a recent history of freshwater recreational activity are those most commonly 
affected. The causative organism and diagnosis are usually confirmed at autopsy. 
Several reviews are available, e.g. [102-109]. 
 
• Viruses: Pharyngo-conjunctival fever outbreaks associated with non-enteric 
adenoviruses in recreational waters have been reported [101]. 
 
• Legionella: Legionella infections have been associated with recreational water 
contact [101].  
 
 
Possible under-diagnosis of cyanobacteria-related illness 
 
The examples given above highlight some of the differential diagnoses that need to be 
worked through when considering possible cases of cyanobacteria-related illness from 
recreational exposures. Competent history-taking and diagnostic microbiology support 
will correctly diagnose many such cases. Competent history-taking and clinical 
diagnostic support also operated in several of the case reports listed in Table 2, with the 
early dermatological testing and microscopic examination of stool and vomitus samples 
lending strong support to the suspicion of cyanobacteria-related morbidity.  
 
 22
Misdiagnosis of cyanobacteria-related disease may occur in both directions. In 1978, 
nearly half the population of an industrial town in Finland were affected by a flu-like 
illness, with symptoms of fever, fatigue, cough, dyspnoea and myalgia. Symptoms 
occurred some 3-6 hours after taking a bath, shower or sauna and persisted for 8-16 
hours. The outbreak lasted for some four months. This epidemic was investigated on 
several fronts, and provocation testing demonstrated an obvious link to the reticulated 
water supply. Tap water was cultured in a range of organic media for fungal and bacterial 
pathogens. No definitive pathogen was identified to explain the epidemic, yet in three 
published reports the authors describe how the shallow lake that was the town water 
source had taken on a distinct opaque blue-green appearance, had a musty smell, and the 
sand filtration system was covered by a mat of cyanobacteria. This change occurred in the 
same month (August, i.e. late summer) that the epidemic began. Analysis of crude lake 
water in the third month after the onset of the epidemic showed high coliform counts, 
Aspergillus fumigatus and unspecified blue-green algae. Investigations centred on 
identifying antibodies to mesophilic actinomycetes, which the authors [110] note were 
not pathogenic, whereas aquatic cyanobacteria were known at the time to be toxic. The 
health workers investigating the outbreak apparently did not consider the possibility of a 
cyanobacterial exotoxin breakthrough into the reticulated supply [110-114]. The 
epidemiological report of Aro et al [111] came closest to suggesting that cyanobacteria 
may have been involved, suggesting that “towards the end of summer….the 
microorganisms in the lake multiply rapidly and produce some toxic substance or 
allergen”, and reported that cyanobacterial endotoxin concentration in lake and tap water 
was high. This incident appears to have been retrospectively attributed to the presence of 
 23
cyanobacterial endotoxins in the reticulated supply [115]. A similar outbreak occurred 
almost three years earlier in a Swedish town, though with a much smaller proportion of 
cases identified. Cyanobacteria were known to affect the town’s raw water supply, and 
the investigators did consider the possibility that cyanotoxins may have been responsible 
for the outbreak [116], though the analytical technique used by investigators at the time – 
gas chromatography – would have failed to detect the presence of cyanobacterial 
exotoxins in the post-treatment water supply. While no conclusions can be made about 
events that occurred over 25 years ago, from the descriptions of the outbreaks and the raw 
water supplies, most cyanobacterial toxicologists would rate cyanotoxin exposure with a 
high index of suspicion. 
 
A similar outbreak occurred more recently in Homa Bay, Kenya, in 1998. Apparently 
associated with a mass development of cyanobacteria in Lake Victoria, an epidemic of 
fever, malaise, dizziness and upper respiratory symptoms was related to hot water 
bathing. Symptoms lasted 12-24 hours, and returned when a shower or bath was taken 
again. This outbreak was reported in a conference abstract; the authors suggested 
cyanobacterial endotoxins were responsible, though it is not stated whether any 
investigation of cyanobacterial exotoxins was conducted [117].  
 
 
Conclusions 
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The true incidence of acute cyanobacteria-associated illness from recreational exposure is 
unknown, as many outcomes are likely to be mild and self-limiting, so medical attention 
is not sought. With a long-standing knowledge gap amongst primary healthcare 
providers, non-specific signs and symptoms caused by cyanobacterial products are likely 
to be under-diagnosed [8]. Codd [118] stated:  
 
“Evidence linking human illnesses with cyanobacterial cells and toxins is open to 
criticism because of shortfalls in early detailed case definitions, because 
diagnoses were made by exclusion, and because identification and  quantification 
of cyanobacterial toxins in health incidents have, until recently, been lacking.” 
 
The collation of anecdotal and case reports of illness associated with recreational 
exposure to cyanobacteria in Table 2 will hopefully highlight some of the knowledge 
gaps. Particular attention should be given to determining the onset and duration of 
individual symptoms in future case reporting, as well as detailing the presence or absence 
of any predisposing medical conditions.  
 
A recent initiative of UNESCO’s International Hydrology Programme has been to 
establish CyanoNet, which is a “Global network for the hazard management of 
cyanobacterial blooms and toxins in water resources”.  The CyanoNet website will carry 
information on various associated topics, including “Reported incidents of adverse health 
effects including case studies” and “Surveys and epidemiological studies investigating 
associations between cyanobacterial populations, cyanotoxins and health” [119]. 
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 The most important advances in understanding the health impacts of cyanobacteria have 
come from the discipline of toxicology. The major toxins have been extensively studied 
and characterised, and while there is still much to be discovered in the field of 
cyanobacterial toxicology, significant advances in the future will be made at the interface 
of toxicology and epidemiology. Molecular epidemiology techniques using yet-to-be 
discovered biomarkers of exposure, susceptibility and outcome will refine knowledge of 
the risks associated with various acute and chronic exposures to cyanotoxins. The 
collaborative skills that epidemiologists and toxicologists can bring to this endeavour 
were visualised with a mildly jaundiced eye by Paddle [120], whose chapter on 
epidemiology for toxicologists is an excellent general primer: 
 
“The total evidence about the risk to humans…will consist of the toxicologist’s 
precise, experimental data about the wrong species at the wrong exposure, and 
the epidemiologist’s imprecise, observational data about the right species at the 
right exposure.” 
 
In conclusion, anecdotal and case reports of variable reliability have suggested a range of 
symptoms are associated with exposure to cyanobacteria in recreational or occupational 
settings. Some reports of cutaneous reactions are strongly suggestive of allergic reactions, 
and symptoms such as rhinitis, conjunctivitis, asthma and urticaria also hint at immediate 
hypersensitivity responses. Flu-like illnesses involving a constellation of symptoms 
including fever, malaise, myalgia, arthralgia, severe headache, cough and sore throat are, 
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in our opinion, explained by a cascade action of pro-inflammatory cytokines. If correct, 
this implies that some cyanobacterial products possess ligands that signal innate immune 
responses, and such responses may need to be considered in terms of their potential to 
direct pathological changes in the liver and other organ systems. 
 
The epidemiology of recreational exposure to cyanobacteria is incomplete at present. All 
common epidemiological approaches have their own inherent advantages and 
disadvantages; identification of biomarkers for exposure, susceptibility and outcome in 
the future should lead to a significantly improved perception of the risks of bathing in 
cyanobacteria-affected waters.  
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Table 1.  Cyanotoxins with public health significance from acute exposures 
 
Toxin or toxin group Classification by 
principal target 
organ systems 
Toxin-producing 
genera 
LD50 (i.p. 
mouse) 
References 
Microcystins Hepatotoxins 
Anabaena, 
Anabaenopsis, 
Aphanocapsa, 
Arthrospira, 
 Hapalosiphon, 
Microcystis, Nostoc, 
Oscillatoria, 
Planktothrix, Snowella, 
Woronichinia  
25->1000 
µg/kg 
[10, 19, 26, 
121-124] 
Nodularins Hepatotoxins Nodularia 30-60 µg/kg [8, 26, 125] 
Anatoxin-a, 
homoanatoxin-a Neurotoxins 
Anabaena, 
Aphanizomenon, 
Arthrospira, 
 Cylindrospermum, 
Microcystis,  
Oscillatoria, 
Phormidium, 
Planktothrix, 
Raphidiopsis 
200-
375µg/kg 
[8, 10, 18, 26, 
126-131] 
Anatoxin-a(s) Neurotoxin Anabaena 20-40µg/kg [8, 26, 128] 
Saxitoxins Neurotoxins 
Anabaena, 
Aphanizomenon, 
Cylindrospermopsis, 
Lyngbya, Planktothrix 
10-30µg/kg [26, 123, 128, 132-136] 
Cylindrospermopsin 
General cytotoxin 
(multiple organ 
systems affected, 
incl. liver, kidney, 
gastrointestinal 
tract, heart, spleen, 
thymus, skin) 
Anabaena, 
Aphanizomenon, 
Cylindrospermopsis, 
Raphidiopsis, Umezakia 
2.1mg/kg 
(24 hours) 
200µg/kg 
(5-6 days) 
[8, 10, 17, 
128, 137-141] 
Aplysiatoxin, 
debromoaplysiatoxin 
Dermal toxins; 
possible gastro-
intestinal 
inflammatory toxin 
Lyngbya 107-117 µg/kg [142-147] 
Lyngbyatoxin A 
Possible gastro-
intestinal 
inflammatory toxin 
Lyngbya 250 µg/kg (?LD100) 
[148] 
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Year Season Location Number 
affected 
Estimates of 
number 
unaffected 
Age Water 
activity 
Signs & 
symptoms 
Dominant 
plankton 
Time of 
onset after 
exposure 
Symptom 
duration 
Diagnostic 
criteria 
Predisposing 
conditions 
Notes References 
 
Hayfever-like symptoms (conjunctivitis, rhinitis, sneezing) 
 
1934 
 
 
Late 
summer 
Muskego Lake, 
Waukesha 
County, WI, USA 
Report of 
single 
subject, 
male 
N/S 57 Swimming Itching of eyes, 
nasal congestion 
“weedy lake” 3 hours <48 hours  History of 
frequent sinus 
infections 
 [53] 
1935 
 
Late 
summer 
Muskego Lake, 
WI, USA 
Same 
subject 
N/S  Swimming Same 
symptoms, + 
mild asthma 
 As above As above    [53] 
1936-
1946 
 
 
Late 
summer 
North Lake, 
Waukesha 
County, WI, USA 
Same 
subject 
N/S  Swimming Nasal discharge 
and congestion, 
conjunctivitis, 
mild asthma 
Oscillatoreaceae 
(sample taken in 
late summer, 
1944) 
N/S N/S Surface scum 
extracts gave 
immediate skin 
reactions. 
Cutaneous 
injection of 
0.03mL of 
1:1,000 dilution 
resulted in mild 
asthma within 20 
mins. Control 
subjects did not 
react to scum 
extracts  
 Subject swam in 
North Lake 
during summer 
months over the 
ten-year period, 
without incident 
until mid-August 
each year, when 
swimming was 
followed by 
symptom onset. 
Desensitisation 
injections over 4 
years were 
successful 
[53] 
1979 
 
 
Late 
summer 
Lake 
Wallenpaupack, 
PA, USA 
5 (family 
group) 
N/S N/S 
(parents 
+ son + 
daughter 
+ friend) 
Swimming “Severe” 
hayfever-like 
symptoms 
(sneezing, nasal 
discharge, eye 
irritation): 3/5 
earache: 2/5 
N/S. Lake 
developed a 
distinct green 
colour several 
days prior to 
incident. Three 
weeks later: 
heavy bloom of 
Anabaena 
Hayfever 
symptoms: 
during 
exposure; 
earache: 
several 
hours after 
exposure 
N/S  N/S  [64] 
1979 
 
 
Late 
summer 
Lake 
Wallenpaupack, 
PA, USA 
20-30 60-90 (those 
affected 
comprised 
approx 25% of 
aquatic event 
participants) 
N/S (high 
school 
students) 
Participating 
in school 
aquatic 
event 
Eye irritation, 
sore throat, 
earache, 
sneezing, nasal 
discharge, 
swollen lips 
N/S. see above During 
exposure or 
within 2-3 
hours 
Within 2-3 
days 
 
*Subsequent 
exposure 
reportedly 
caused re-
occurrence of 
symptoms  
 N/S Affected 
individuals were 
members of a 
high school 
summer aquatic 
program. The 
event was 
cancelled 
because of 
these illnesses 
[64] 
N/S 
 
N/S N/S Single male N/S N/S 
(adult) 
Swimming Hayfever-like 
symptoms 
Bloom of 
Microcystis 
N/S N/S  N/S  [149] 
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Year Season Location Number 
affected 
Estimates of 
number 
unaffected 
Age Water 
activity 
Signs & 
symptoms 
Dominant 
plankton 
Time of 
onset after 
exposure 
Symptom 
duration 
Diagnostic 
criteria 
Predisposing 
conditions 
Notes References 
 
Cutaneous symptoms  
[54] 1949-
1952 
 
 
Summer Lake Carey, PA, 
USA  
Report of 
single 
subject, 
female 
Reported skin 
rash “never 
appeared in 
other bathers 
swimming in 
the same 
water” 
6 
(condition 
first seen 
at age 3 
years) 
Swimming Seasonal 
erythematous 
papulo-vesicular 
rash, 
occasionally 
progressing to 
oozing and 
crusting. Rash 
limited to face, 
neck, shoulders, 
upper chest and 
extremities; rash 
never seen on 
areas covered 
by swimsuit 
Anabaena 1-2 hours < 2 weeks (if 
no further 
contact with 
lake water) 
Skin patch 
testing: strong 
positives to 
Anabaena 
filtered from lake 
water, 
chloroform 
extract of same, 
and phycocyanin 
extract 
None (apart 
from reported 
condition) 
Rash never seen 
after swimming 
in artificial pools 
or ocean. Only 
seen after water 
exposure at 
Lake Carey, and 
once after 
bathing in a 
Canadian lake 
Late 
1940s 
& mid 
1950s 
Late 
summer 
Lake Ringsjön, 
Scania, Sweden 
“several” 
members of 
a family 
N/S N/S 
(“young 
girl” + 
siblings) 
Swimming Pruritic skin 
rashes 
Gloeotrichia 
echinulata 
N/S N/S    [150, 151] 
1977 Summer Mingechaur 
Reservoir, 
Azerbaijan 
7 13 N/S Swimming Slightly raised, 
erythematous 
spots, 2-6mm 
diameter; seen 
on skin 
bordering and 
outside swimsuit 
Benthic Lyngbya 
kützingii; also 
“planktonic blue-
green algae 
colouring the 
water” 
2nd day after 
swimming 
10-12 days    [40] 
1985 
 
N/S UK N/S N/S N/S Sail-
boarding 
Skin rashes N/S (“toxic 
blooms”) 
N/S N/S  N/S  [61] 
1989 
 
N/S Japan (lake) 1 N/S N/S 
(adult) 
Collecting 
algal scum * 
Rashes M. aeruginosa 
containing 
microcystins 
N/S N/S  N/S  [61] 
1989 
 
 
Late 
summer – 
early 
autumn 
Bewl Water, 
Kent, UK 
1 N/S N/S Fishing ‘blotchy’ skin on 
face and hands 
after handling 
water on three 
separate 
occasions 
Microcystis sp Within two 
hours 
Several days  N/S  [61] 
1989 
 
N/S NRA South West 
Region, UK 
N/S (“some 
NRA staff”) 
N/S N/S 
(adults) 
Sampling 
water * 
Tingling 
sensations on 
hands 
“Potentially 
toxic 
cyanobacteria 
species” 
N/S N/S  N/S  [61] 
1989 
 
Early-mid 
autumn 
Welton Water, 
Yorks, UK 
N/S N/S N/S N/S (“water 
users”) 
Rashes Anabaena sp N/S N/S  N/S  [61] 
1991 
 
 
 
Late 
spring – 
early 
summer 
Darling-Barwon 
river system, 
NSW, Australia 
N/S N/S N/S 
(adults) 
Sampling 
water* 
Skin irritation Anabaena spp N/S N/S  N/S  [152] 
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Year Season Location Number 
affected 
Estimates of 
number 
unaffected 
Age Water 
activity 
Signs & 
symptoms 
Dominant 
plankton 
Time of 
onset after 
exposure 
Symptom 
duration 
Diagnostic 
criteria 
Predisposing 
conditions 
Notes References 
 
 Cutaneous symptoms 
 
2003 Summer Lake Salajärvi 1 N/S N/S Swimming Rash Anabaena 
lemmermannii 
(dominant) + 
minor 
proportions of M. 
aeruginosa and 
M. flos-aquae. 
Saxitoxin, 
microcystins and 
anatoxin-a 
products present 
in water samples 
N/S N/S  N/S  [153] 
2003 N/S Lake Sompanen, 
Finland 
1 N/S 7 yo male N/S “extensive” 
generalised rash 
Cyanobacteria 
visible in water; 
saxitoxin found 
in water samples 
in 2002 & 2004 
N/S N/S  N/S  [153] 
 
 
Gastro-intestinal symptoms (nausea, vomiting, diarrhoea, abdominal pain) 
 
1959 
 
 
Summer One of Katepwa 
Lakes, SK, 
Canada 
Report of 
single 
subject, 
male 
N/S N/S 
(adult) 
Swimming Headache, 
nausea, G-I 
upset 
N/S During night 
after 
swimming 
<48 hours.  Stool sample 
showed “many 
tiny greenish 
spheres which 
resembled in 
size and 
morphology the 
cells of 
Microcystis”. 
Stool specimen 
negative for 
Salmonella and 
Entamoeba 
N/S Subject sought 
medical advice 
for 
gastroenteritis, 
admitted to 
hospital, given 
oral 
chloramphenicol. 
Recovery within 
24 hours of 
admission 
[55] 
1959 
 
 
Summer Long Lake, SK, 
Canada 
10 N/S N/S 
(children) 
Swimming Diarrhoea, 
vomiting 
N/S. Subjects 
swam in “algae-
covered lake 
water”. Dried 
Microcystis and 
Anabaena scum 
found later on 
shore 
N/S. 
Reported to 
local 
medical 
officer with 
illness on 
the day 
after 
exposure 
N/S Stool specimen 
from one child 
contained cells 
resembling 
Anabaena “in 
great numbers” 
 Local farmer 
reported that two 
cows died after 
drinking from the 
lake 12-16 hours 
previously, 
during an algal 
bloom. A third 
sick cow 
recovered after 
receiving 
penicillin 
injections  
[55] 
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Year Season Location Number 
affected 
Estimates of 
number 
unaffected 
Age Water 
activity 
Signs & 
symptoms 
Dominant 
plankton 
Time of 
onset after 
exposure 
Symptom 
duration 
Diagnostic 
criteria 
Predisposing 
conditions 
Notes References 
 
Gastro-intestinal symptoms (nausea, vomiting, diarrhoea, abdominal pain) 
 
N/S 
 
 
N/S N/S (lake) Single 
subject, 
male  
N/S 4 Fell into 
lake, 
swallowed 
water # 
Abdominal pain, 
nausea, 
vomiting, 
diarrhoea, 
wooziness, 
headache, thirst 
N/S Day of 
exposure: 
G-I 
symptoms; 
next day: 
wooziness, 
headache, 
thirst 
N/S Aphanizomenon 
found in stool 
and vomitus 
specimens 
N/S  [63] 
1961 
 
N/S N/S 4 N/S N/S 
(students) 
Swimming Headache, 
malaise, 
diarrhoea 
Heavy growth of 
Microcystis and 
Anabaena 
N/S N/S  N/S  [63] 
1989 
 
 
Early 
autumn 
Rutland Water, 
Leics, UK 
N/S N/S 2 & 3 
year-olds 
Playing at 
edge of 
scum 
Vomiting & 
diarrhoea 
M. aeruginosa N/S N/S Microcystin-LR 
found to be 
principal 
cyanobacterial 
toxin present 
N/S 20 sheep and 15 
dogs died over 
approx 3 weeks 
in late summer – 
early spring after 
contact with 
bloom scum 
[6] 
1990 
 
 
N/S Unnamed lake, 
Tiel, The 
Netherlands 
N/S N/S N/S Swimming “G-I complaints” Anabaena flos-
aquae 
N/S N/S Water quality 
parameters and   
food-borne 
pathogen testing 
negative 
 
N/S Mouse bioassay 
and HPLC-UV 
confirmed 
presence of 
anatoxin-a 
[154] 
 
2003 Summer Lake Iso-
Kukkanen, 
Finland 
1 N/S 10 yo 
male 
Swimming Abdominal pains A. lemmermannii 
sole or dominant 
cyanobacterium. 
Saxitoxin 
measured at 13-
270 µg/L 
(depending on 
methods). Low 
levels of 
microcystins 
found. Anatoxin-
a and 
degradation 
products 
reported 
N/S Several hours  N/S  [153] 
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conditions 
Notes References 
 
Progression to fatal illness 
 
2002 
 
 
Mid-
summer 
Golf course 
pond, 
Milwaukee, WI, 
USA 
5 0 17 yo 
male and 
4 friends 
“splashing 
and diving”. 
Two most 
severely 
affected 
boys had 
their heads 
under water 
for varying 
periods of 
time # 
17-year-old 
developed 
nausea, 
vomiting, 
progressed to 
“shock” and 
“seizure”, acute 
heart failure; 
death ensued 
approx. 48 hours 
after exposure. 
One teenager 
who also 
apparently 
ingested water 
developed 
severe diarrhoea 
and abdominal 
pain. The other 
three youths 
developed 
“minor 
symptoms” 
Presumably A. 
flos-aquae 
containing 
anatoxin-a, 
determined from 
blood and stool 
samples of the 
boy that died 
and the other 
severely affected 
youth 
N/S N/S Analysis of 
“tissue, blood 
and other fluid 
samples” from 
the two severely 
affected 
teenagers. 
Anatoxin-a found 
in unspecified 
sample/s. 
Autopsy showed 
“acute heart 
damage” but no 
evidence of 
meningitis or 
encephalitis.  
Analyses for 
pesticides, 
parasites and 
other pathogens 
negative  
N/S  The unusual 
feature of this 
case is the 
length of time – 
48 hours – that 
ensued between 
exposure and 
ingestion of 
contaminated 
water and 
subsequent 
death. 
Uncertainty 
exists regarding 
the identification 
of anatoxin-a in 
tissue samples 
[41, 42, 58-
60] 
 
Cold & flu-like symptoms (incl. fever, headache, myalgia, arthralgia, sore throat, respiratory and gastro-intestinal) 
 
1959 
 
 
Summer Echo Lake, SK, 
Canada 
Report of 
single 
subject, 
male  
N/S N/S 
(adult) 
Intending to 
swim – fell 
into lake, 
swallowed 
an 
estimated 
half-pint of 
water # 
Abdominal 
cramps and 
pain, nausea, 
vomiting, painful 
diarrhoea, fever, 
severe 
headache, 
weakness, pain 
in limb muscles 
and joints. 
Stools and 
vomitus were 
slimy and green 
N/S. Lake had a 
visible bloom on 
day of exposure.   
Microcystis and 
Anabaena bloom 
35 days prior to 
exposure 
3 hours: 
abdominal 
pain, 
nausea, 
vomiting 
5 hours: 
diarrhoea; 
next 
morning: 
fever, 
headache, 
myalgia, 
weakness  
Recovering 
when 
questioned on 
2nd day after 
exposure 
Stool specimen 
showed 
“innumerable 
spheres of 
Microcystis and 
2-3 well-
preserved 
curved chains of 
A. circinalis per 
high-power field” 
N/S During bloom 35 
days prior to 
exposure, an 
unknown 
number of dogs 
and geese died 
after swimming 
in the lake. 
Other dogs 
sickened after 
drinking lake 
water. Also fish 
kills 
[55] 
N/S 
 
 
N/S N/S (swimming 
hole) 
Single 
subject, 
male 
N/S 12 Swimming Fever, loss of 
consciousness 
for six hours, 
dyspnoea, 
pneumonia, 
myalgia, 
arthralgia 
Abundant M. 
aeruginosa 
N/S (onset 
reported as 
sudden, 
with 
subsequent 
myalgia and 
arthralgia) 
N/S Stool sample: 
Aeromonas 
(Gram-negative 
bacteria), 
Spirogyra and 
Mougeotia (both 
green algae) 
 
N/S  [63] 
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Year Season Location Number 
affected 
Estimates of 
number 
unaffected 
Age Water 
activity 
Signs & 
symptoms 
Dominant 
plankton 
Time of 
onset after 
exposure 
Symptom 
duration 
Diagnostic 
criteria 
Predisposing 
conditions 
Notes References 
 
Cold & flu-like symptoms (incl. fever, headache, myalgia, arthralgia, sore throat, respiratory and gastro-intestinal) 
1979 
 
 
Late 
summer 
Lake 
Wallenpaupack, 
PA, USA 
15 N/S N/S Swimming Vomiting, 
nausea, 
diarrhoea, eye 
irritation, sore 
throat, fever, 
earache 
N/S. See above.  Symptoms 
occurred “a 
short time 
after contact 
with lake 
water” 
G-I symptoms: 
24-48 hours 
 N/S Affected 
individuals all 
holidaying in 
rental cottages. 
Well water to 
cottages free of 
bacterial 
contamination 
 
[64] 
1979 
 
 
Late 
summer 
Arrowhead Lake, 
PA, USA 
Single 
female 
 
N/S N/S 
(“young 
girl”) 
Swimming # Chills, sore 
throat, fever, 
nausea, 
diarrhoea 
N/S “within 
several 
hours” 
Approx. 3 
days 
 N/S  [64] 
1989 
 
 
Early 
autumn 
Rudyard Lake, 
Staffs, UK 
2 N/S 16  Swimming 
and 
canoeing 
exercises, 
the latter 
involving 
3600 rolls * 
# 
Malaise, sore 
throat, circum-
oral blistering, 
left-sided 
pleuritic pain, dry 
cough, vomiting, 
central 
abdominal pain, 
diarrhoea, fever 
 
M. aeruginosa Day after 
exposure 
<2 weeks Microcystin-LR 
found to be 
principal 
cyanobacterial 
toxin present 
N/S Both were 
hospitalised, 
having developed 
left lower-lobe 
pneumonia 
accompanied by 
thrombocytopenia 
[23, 57, 70, 
155, 156] 
1989 
 
 
Early 
autumn 
Rudyard Lake, 
Staffs, UK 
8 N/S N/S 
(soldiers) 
As above * 
# 
Sore throat, 
headache, 
abdominal pain, 
dry cough, 
diarrhoea, 
vomiting, 
blistered mouth 
M. aeruginosa  N/S N/S See above N/S All subjects were 
soldiers who had 
partaken in 
canoeing 
exercises, 
subsequently 
admitted to 
barracks medical 
centre 
 
[23, 57, 70, 
155, 156] 
1992 
 
 
Mid-
spring 
Darling River, 
Wilcannia, NSW, 
Australia 
2 N/S N/S - 
teenagers 
Swimming Gastroenteritis 
and myalgia 
Anabaena sp N/S Symptoms 
resolved after 
48 hrs 
One subject 
required 
admission to 
hospital.  
N/S Some Wilcannia 
residents 
reported itchy 
skin rashes after 
showering, even 
after carbon 
filtration of the 
town water 
supply 
[157] 
N/S 
 
 
N/S Unnamed 
reservoir, UK 
Single 
subject, 
male 
N/S 39 Windsurfing Fever, nausea, 
vomiting 
N/S, but 
microcystin 
isolated from 
reservoir; 
several sheep 
and dogs died 
 
N/S “shortly 
after 
windsurfing 
trip” 
N/S Liver function 
tests, liver 
biopsy 
No significant 
past history, 
no 
medications 
Mild hepatic 
dysfunction 
investigated six 
weeks after 
exposure 
[158] 
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Mixed symptoms 
[53] 1945 
 
 
Late 
summer 
Lake Keesus, 
Waukesha 
County, WI, USA 
Report of 
single 
subject, 
female 
N/S 39 Swimming Gross eyelid 
oedema, nasal 
congestion, 
generalised 
urticarial rash  
N/S “while 
swimming” 
N/S Skin test with 
Oscillatoreaceae 
extract (0.03mL 
of 1:10,000 
dilution) resulted 
in immediate 
and severe local 
reaction treated 
by local injection 
of adrenaline 
Long-standing 
history of 
autumn hay-
fever and 
seasonal 
asthma 
Oscillatoreaceae 
extracts elicited 
positive (but 
unspecified) 
reactions in 
“many 
individuals who 
knew that 
swimming 
caused hay 
fever” at 
dilutions up to 
1:100,000  
1946 
 
Late 
summer 
Lake Keesus, 
WI, USA 
Same 
subject 
N/S  Swimming As above N/S N/S N/S    [53] 
1973-4 
 
 
Summer Belgrano Park 
pond, Santa Fe 
City, Argentina 
N/S N/S N/S Swimming 
and bathing 
G-I symptoms, 
dermatitis, otitis, 
conjunctivitis 
Mainly M. 
aeruginosa; 
bloom contained 
“up to 60,000 
colonies/mL” 
N/S N/S N/S N/S  [159] 
1979 
 
 
Late 
summer 
Arrowhead Lake, 
PA, USA 
Initial 
reports: 20-
30 children, 
several 
adults. 12 
children + I 
adult 
investigated 
N/S 4-12, + 
adult 
Swimming Headache: 8/13 
stomach 
cramps: 9/13 
nausea: 5/13 
vomiting: 7/13 
diarrhoea: 11/13 
fever: 5/13 
rash: 1/13 
sore or inflamed 
throat: 3/13 
N/S During 
exposure, to 
maximum 
12 hours 
after 
exposure. 
Rash on 
arms & legs 
of adult ♀ 
developed 
“shortly 
after wading 
along lake 
edge” 
Most 
symptoms: 
<72 hours 
All symptoms: 
≤5 days 
Stool samples of 
four children 
negative for 
Salmonella and 
Shigella. Throat 
swab of one 
child with sore 
throat negative 
for viral 
involvement 
N/S Routine weekly 
monitoring for 
faecal coliforms 
showed counts 
were ≤40/100mL 
prior to incident 
[64] 
1980 
 
 
Mid-
summer 
Pocono 
Highlands Lake, 
PA, USA 
N/S 
“swimmers” 
N/S N/S Swimming Eye irritation, 
earache, sore 
throat 
Anabaena sp. N/S N/S Water samples 
produced signs 
of poisoning in 
mice suggestive 
of hepatotoxin. 
LD50 = 90 mg/kg  
(i.p. mouse) 
N/S  [56] 
1980 
 
 
Late 
summer 
Lake Lahonton, 
NV, USA 
N/S 
“several… 
affected ” 
N/S N/S Water 
skiing, 
swimming 
Erythema, eye 
irritation, 
dizziness, 
nausea, 
stomach 
cramps, diarrhea 
 
Aphanizomenon 
flos-aquae 
N/S N/S LD50 = 500 
mg/kg body 
weight (i.p. 
mouse) 
N/S  [56] 
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Mixed symptoms 
 
1980 
 
 
Mid-
summer 
Camp William 
Penn, PA, USA 
75-100 N/S N/S N/S 
(“campers 
affected 
from contact 
with water”) 
Conjunctivitis, 
sore-red throat, 
headaches, 
diarrhoea, 
nausea 
 
 
 
Anabaena sp. N/S N/S  N/S  [56] 
1981 
 
 
Mid-
summer 
Harveys Lake, 
PA, USA 
N/S (“many 
reports…”) 
N/S N/S N/S Skin irritation, 
nausea, 
dizziness, 
diarrhoea 
Anabaena flos-
aquae 
N/S N/S Mouse toxicity 
testing of water 
showed both 
neurotoxins and 
hepatotoxins 
present. LD50 = 
125 mg/kg 
N/S Lake closed to 
public access 
until early spring 
[56] 
1989 
 
 
Early 
autumn 
Rutland Water, 
Leics, UK, and 
other UK lakes 
N/S 
(“several”) 
N/S N/S Sail-
boarding # 
Skin rashes, 
nausea, 
vomiting, 
blistering inside 
mouth, severe 
thirst 
M. aeruginosa N/S N/S Microcystin-LR 
found to be 
principal 
cyanobacterial 
toxin present 
N/S 20 sheep and 15 
dogs died over 
approx 3 weeks 
in late summer – 
early spring after 
contact with 
bloom scum 
[6, 61, 155] 
1990 
 
 
Spring Lake Cargelligo, 
NSW, Australia 
2 or 3 N/S N/S Swimming Two cases of 
conjunctivitis, 
one case of rash 
Anabaena 
circinalis 
N/S N/S  N/S Lake closed as 
water supply for 
one month while 
bloom evident 
[62] 
  
1991 
 
 
Summer-
Autumn 
Lakes 
Alexandrina and 
Albert, SA, 
Australia 
1 N/S N/S 
(adult) 
Crayfishing Skin and/or eye 
symptoms 
(pruritus, skin 
rash, sore red 
eyes) 
Nodularia sp N/S N/S Case identified 
retrospectively 
by either 
interview with 
local residents, 
local health 
workers or 
surveillance 
through local 
GPs 
N/S 7 other cases 
identified, all 
with skin and/or 
eye symptoms. 
Two of them 
also had asthma 
symptoms, one 
had hay fever 
symptoms, 
another a sore 
throat. Water 
contact was by 
showering or 
bathing 
[160] 
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Mixed symptoms 
 
1991 
 
 
Late 
spring – 
early 
summer 
Darling River, 
Wilcannia, NSW, 
Australia 
1 Sole report 
after 
surveillance 
requests to 
report 
confirmed or 
suspected 
cyanobacteria
-related illness 
during an 
extensive 
riverine bloom 
N/S 
(adult) 
Water skiing Skin rash, 
conjunctivitis, 
diarrhoea, 
respiratory 
difficulty 
Anabaena spp N/S N/S  N/S All schools along 
the river system 
were asked to 
report increases 
in illness-related 
absenteeism, 
especially for G-I 
symptoms. No 
such increase 
was reported 
[152] 
1991-2 
 
 
Summer River Murray, 
SA, Australia 
11 N/S 1-64 “water 
sport…. 
particularly 
skiing”. One 
of these 
cases had 
skin contact 
through 
both water 
sport and 
residential 
water use 
Contact 
exposure (n=2): 
rash, itching, 
mouth blistering, 
eye irritation; 
oral ingestion 
(n=3): diarrhoea, 
vomiting, 
nausea, muscle 
weakness, sore 
throat, 
respiratory 
difficulty, 
headache; 
contact + oral 
exposure (n=6): 
mixture of above 
symptoms  
Predominantly 
A. circinalis 
N/S N/S Cases 
investigated 
following 
telephone or 
personal 
complaints to 
health 
authorities and 
water supply 
management 
N/S 15 further cases 
with exposure to 
River Murray 
water from 
reticulated water 
supply 
[161] 
1994 N/S Lake Velencei, 
Hungary 
100-150 N/S children 
at a youth 
camp 
N/S skin and eye 
irritation 
“heavy bloom” of 
M. aeruginosa 
N/S N/S N/S N/S  [162] 
1996 
 
N/S Hollingworth 
Lake, UK 
11 N/S N/S (sea 
cadets) 
Canoe 
capsizing 
trials * 
Facial rashes, 
asthmatic signs, 
dry sporadic 
cough, vomiting 
Planktothrix 
agardhii, 
containing three 
microcystins  
Day of, and 
after 
exposure 
N/S  N/S  [23] 
1997 
 
 
Autumn Lake 
Sammamish, 
WA, USA 
N/S 
(“several”) 
N/S “young 
children” 
Swimming G-I complaints, 
rashes 
M. aeruginosa, 
microcystins 
measured at 
approx. 500 µg/g 
dry weight 
N/S N/S N/S N/S A dog began 
“heaving and 
coughing”, died 
four hours after 
exposure to 
bloom 
[43, 44] 
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Mixed symptoms 
 
2003 N/S Lake Iso-
Kukkanen, 
Finland 
1 N/S 2 yo child Swimming Fever and eye 
irritation 
A. lemmermannii 
sole or dominant 
cyanobacterium. 
Saxitoxin 
measured at 13-
270 µg/L 
(depending on 
methods). Low 
levels of 
microcystins 
found. Anatoxin-
a and 
degradation 
products 
reported 
N/S N/S  N/S  [153] 
 
# – cyanobacteria-affected water reportedly ingested (table column: “Water activity”) 
 
* – occupational exposure (table column: “Water activity”) 
 
N/S – not stated 
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Table 3. Summary of epidemiological studies investigating recreational exposure to cyanobacteria 
 
Country; year study 
conducted; study 
author/s; reference 
Study design Study size (n) Main outcomes reported 
Proportion of exposed 
subjects from which 
statistically significant 
findings were drawn 
(%) 
Odds ratio (95% 
confidence 
interval) 
UK, 1990 
Philipp [82] 
Analytical cross-
sectional 246 No statistically significant findings 
  
UK, 1990 
Philipp & Bates [83] 
Analytical cross-
sectional 363 No statistically significant findings 
  
UK, 1990 
Philipp et al [84] 
Analytical cross-
sectional 246 No statistically significant findings 
  
Australia, 1992 
El Saadi et al [85] Case-control 
Approx. 48 
(subjects 
reporting 
recreational 
exposure) 
No statistically significant findings 
  
Australia, 1995 
Pilotto et al [86] Prospective cohort 852 
Increased symptoms at seven days following 
exposure amongst subjects exposed to more 
than 5,000 cyanobacterial cells/mL for more 
than one hour compared to non-bathers 
10.9 3.44 (1.09, 10.82) 
Australia & USA,  
1999 - 2002 
Stewart et al [87] 
Prospective cohort 1,331 
Increased reporting at three days following 
exposure of  mild respiratory and pooled 
symptoms amongst those exposed to 
cyanobacteria levels exceeding 12mm2/mL 
compared to subjects exposed to less than 
2.4mm2/mL 
11.2 
 
1.7 (1.0, 2.8) (any 
symptom) 
 
2.1 (1.1, 4.0) 
(respiratory 
symptoms) 
 
 
 
 
